Evidence mapPaperPMID 28655015Full record

Trial reportJAMA2017

Effect of Acupuncture and Clomiphene in Chinese Women With Polycystic Ovary Syndrome: A Randomized Clinical Trial.

Xiao-Ke Wu, Elisabet Stener-Victorin, Hong-Ying Kuang, Hong-Li Ma, Jing-Shu Gao, Liang-Zhen Xie, Li-Hui Hou, Zhen-Xing Hu, Xiao-Guang Shao, Jun Ge and 26 more

3 registry-linked trialsOpen access · bronzeAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in JAMA, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 105 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed, 12 pooled it
22.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01573858 nacompletednot on this map

Effect of Acupuncture and Clomiphene Citrate on Live Birth in Anovulatory Women With Polycystic Ovary Syndrome: A Randomized Controlled Trial (PCOSAct)

TypeinterventionalSponsorHeilongjiang University of Chinese MedicineRan2012 to 2015Enrolled1,000ConditionsPregnancy, Polycystic Ovary Syndrome, InfertilityArmsAcupuncture treatment 1, Acupuncture treatment 2, CC, CC placebo
NCT03625531 phase3completednot on this mapstarted 2018, after this paper: background citation

A Multicenter Randomized Trial of Personalized Acupuncture, Fixed Acupuncture, Letrozole and Placebo on Live Birth for Infertility in Women With Polycystic Ovary Syndrome

TypeinterventionalSponsorHongxia MaRan2018 to 2025Enrolled1,103ConditionsPolycystic Ovary SyndromeArmsAcupuncture, Letrozole, Placebo letrozole
NCT05244811 phase3unknown statusnot on this mapstarted 2022, after this paper: background citation

Treatment of Functional Ovarian Cyst Randomised Clinical Trial

TypeinterventionalSponsorSohag UniversityRan2022 to 2023Enrolled60ConditionsOvarian NeoplasmsArmsCombined Oral Contraceptive, Progestin
3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 12 syntheses or guidelines pooled it, 188 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Acupuncture for polycystic ovarian syndrome.The Cochrane database of systematic reviews · 2019
    Pooled it
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

36 authors at 20 institutions in 4 countries.

Xiao-Ke WuCommittee of Reproductive Medicine, World Federation of Chinese Medicine Societies, Beijing, China2Department of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
Elisabet Stener-VictorinDepartment of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China3Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Hong-Ying KuangDepartment of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
Hong-Li MaDepartment of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
Jing-Shu GaoDepartment of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
Liang-Zhen XieDepartment of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
Li-Hui HouDepartment of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
Zhen-Xing HuOutpatient Department, Xuzhou Maternal and Children's Hospital, Xuzhou, China.
Xiao-Guang ShaoCentre for Reproductive Medicine, Dalian Maternal and Children's Centre, Dalian, China.
Jun GeDepartment of Infertility, Tanggu District Maternal and Children's Hospital, Tianjin, China.
Jin-Feng ZhangDepartment of Obstetrics and Gynecology, Shanxi Province Hospital of Chinese Medicine, Taiyuan, China.
Hui-Ying XueCentre for Reproductive Medicine, Huaian Maternal and Children's Hospital, Huaian, China.
Xiao-Feng XuDepartment of Gynecology, Suzhou City Hospital of Chinese Medicine, Suzhou, China.
Rui-Ning LiangDepartment of Gynecology, Second Hospital, Jiangxi University of Chinese Medicine, Nanchang, China.
Hong-Xia MaDepartment of Chinese Medicine, First Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.
Hong-Wei YangDepartment of Infertility, Liwan District Hospital of Chinese Medicine, Guangzhou, China.
Wei-Li LiDepartment of Obstetrics and Gynecology, Affiliated Hospital, Anhui University of Chinese Medicine, Hefei, China.
Dong-Mei HuangInstitute of Integrated Traditional and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yun SunDepartment of Gynecology, Wenzhou City Hospital of Chinese Medicine, Wenzhou, China.
Cui-Fang HaoCentre for Reproductive Medicine, Yuhuangding Hospital, Yantai, China.
Shao-Min DuDepartment of Obstetrics and Gynecology, Daqing Longnan Hospital, Daqing, China.
Zheng-Wang YangDepartment of Obstetrics and Gynecology, First Affiliated Hospital, Hunan University of Chinese Medicine, Changsha, China.
Xin WangDepartment of Obstetrics and Gynecology, First Affiliated Hospital, Liaoning University of Chinese Medicine, Shenyang, China.
Ying YanDepartment of Gynecology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Xiu-Hua ChenDepartment of Traditional Technology, Guangdong Province Hospital of Chinese Medicine, Guangzhou, China.
Ping FuDepartment of Gynecology, Hangzhou City Hospital of Chinese Medicine, Hangzhou, China.
Cai-Fei DingCentre for Reproductive Medicine, Zhejiang Province Hospital of Integrative Medicine, Hangzhou, China.
Ya-Qin GaoCentre for Reproductive Medicine, Daqing Oilfield General Hospital, Daqing, China.
Zhong-Ming ZhouDepartment of Obstetrics and Gynecology, Hubei Province Hospital of Chinese Medicine, Wuhan, China.
Chi Chiu WangDepartment of Obstetrics and Gynecology, The Chinese University of Hong Kong, Hong Kong, China27Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong, China28School of Biomedical Sciences, The Chinese University of Hong Kong, Hong Kong, China.
Tai-Xiang WuChinese Clinical Trial Registry, Shenzhen, China.
Jian-Ping LiuCentre for Evidence-Based Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
Ernest H Y NgDepartment of Obstetrics and Gynecology, The University of Hong Kong, Hong Kong, China.
Richard S LegroDepartment of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China32Department of Obstetrics and Gynecology, Pennsylvania State University, Hershey.
Heping ZhangDepartment of Biostatistics, Yale University School of Public Health, New Haven, Connecticut.
PCOSAct Study Group
First Affiliated Hospital of Heilongjiang University of Chinese Medicine · CNAnhui University of Traditional Chinese Medicine · CNBeijing Royal Integrative Medicine Hospital · CNBeijing University of Chinese Medicine · CNChinese University of Hong Kong · CNDalian Maternal and Child Health Hospital · CNDaqing City People's Hospital · CNDaqing Oilfield General Hospital · CNFirst Affiliated Hospital of Hunan University of Traditional Chinese Medicine · CNFirst Teaching Hospital of Tianjin University of Traditional Chinese Medicine · CNGuangdong Provincial Hospital of Traditional Chinese Medicine · CNGuangzhou Liwan District Traditional Chinese Medicine Hospital · CNGuangzhou Medical University · CNHangzhou Hospital of Traditional Chinese Medicine · CNHeilongjiang University of Chinese Medicine · CNHuaian First People’s Hospital · CNHubei Provincial Women and Children's Hospital · CNKarolinska Institutet · SELiaoning University · CNPennsylvania State University · US

Funding

Yale Clinical and Translational Science AwardUL1TR001863 · YALE UNIVERSITY · 2025 to 2025
$9.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

Importance: Acupuncture is used to induce ovulation in some women with polycystic ovary syndrome, without supporting clinical evidence. Objective: To assess whether active acupuncture, either alone or combined with clomiphene, increases the likelihood of live births among women with polycystic ovary syndrome. Design, Setting, and Participants: A double-blind (clomiphene vs placebo), single-blind (active vs control acupuncture) factorial trial was conducted at 21 sites (27 hospitals) in mainland China between July 6, 2012, and November 18, 2014, with 10 months of pregnancy follow-up until October 7, 2015. Chinese women with polycystic ovary syndrome were randomized in a 1:1:1:1 ratio to 4 groups. Interventions: Active or control acupuncture administered twice a week for 30 minutes per treatment and clomiphene or placebo administered for 5 days per cycle, for up to 4 cycles. The active acupuncture group received deep needle insertion with combined manual and low-frequency electrical stimulation; the control acupuncture group received superficial needle insertion, no manual stimulation, and mock electricity. Main Outcomes and Measures: The primary outcome was live birth. Secondary outcomes included adverse events. Results: Among the 1000 randomized women (mean [SD] age, 27.9 [3.3] years; mean [SD] body mass index, 24.2 [4.3]), 250 were randomized to each group; a total of 926 women (92.6%) completed the trial. Live births occurred in 69 of 235 women (29.4%) in the active acupuncture plus clomiphene group, 66 of 236 (28.0%) in the control acupuncture plus clomiphene group, 31 of 223 (13.9%) in the active acupuncture plus placebo group, and 39 of 232 (16.8%) in the control acupuncture plus placebo group. There was no significant interaction between active acupuncture and clomiphene (P = .39), so main effects were evaluated. The live birth rate was significantly higher in the women treated with clomiphene than with placebo (135 of 471 [28.7%] vs 70 of 455 [15.4%], respectively; difference, 13.3%; 95% CI, 8.0% to 18.5%) and not significantly different between women treated with active vs control acupuncture (100 of 458 [21.8%] vs 105 of 468 [22.4%], respectively; difference, -0.6%; 95% CI, -5.9% to 4.7%). Diarrhea and bruising were more common in patients receiving active acupuncture than control acupuncture (diarrhea: 25 of 500 [5.0%] vs 8 of 500 [1.6%], respectively; difference, 3.4%; 95% CI, 1.2% to 5.6%; bruising: 37 of 500 [7.4%] vs 9 of 500 [1.8%], respectively; difference, 5.6%; 95% CI, 3.0% to 8.2%). Conclusions and Relevance: Among Chinese women with polycystic ovary syndrome, the use of acupuncture with or without clomiphene, compared with control acupuncture and placebo, did not increase live births. This finding does not support acupuncture as an infertility treatment in such women. Trial Registration: clinicaltrials.gov Identifier: NCT01573858.

Indexed as

Acupuncture TherapyAdultBody Mass IndexClomipheneCombined Modality TherapyContusionsDiarrheaDouble-Blind MethodDrug Administration ScheduleFemaleFertility Agents, FemaleHumansInfertility, FemaleLive BirthPolycystic Ovary SyndromePregnancyClomipheneFertility Agents, Female

Identifiers

PMID28655015
PMCPMC5815063
OpenAlexW2727551680

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.